Caregen (CEO Yongji Jeong), a synthetic peptide-based biotechnology company, announced that it successfully held the 'Global Partners Meeting 2025' on the 15th and 16th. Approximately 50 key overseas partner company officials from 30 countries around the world attended the event, lighting up the event.
Attendees toured Caregen’s research lab and production facilities, experienced cutting-edge technology and excellent manufacturing capabilities, and had a meaningful time sharing success stories and global market strategies and experiences with partner companies from each country using Caregen products. In addition, a dinner and networking session were held to strengthen the intimacy and bond between partners, and to share each other’s culture and business environment.
In particular, this event was held ahead of the overseas registration and launch of Caregen's new health functional foods, MyoKi and Korglutide, and was held at an important time to accelerate global expansion. During the event, there were active and substantive discussions, such as strategic discussions with partners from each country, as well as improving product understanding and establishing a collaboration roadmap.
At the event, CEO Jeong Yong-ji said, “Global warming and climate change are becoming issues worldwide, leading to aging and health problems. Now, prevention and treatment strategies using peptides are important.” He introduced Caregen’s innovative next-generation peptide product line currently under development for anti-aging, anti-fine dust, height growth, oral and bone health, and took the time to directly introduce and communicate its mid- to long-term portfolio expansion plan and global growth strategy. He continued, “This event was a very meaningful opportunity to share our future vision with partners around the world and design an execution strategy for market expansion together.” He emphasized, “We are preparing for a new leap forward in the global market centered on MyoKi and Korglutide, and close cooperation with overseas partners is more important than ever.”
Partners who attended the event also gave high marks to Caregen’s technology and production capabilities. An overseas partner official said, “Caregen’s R&D infrastructure and technology are world-class, and the collaboration with Caregen is a very strategic opportunity for us,” adding, “We plan to continue our close collaboration in the future.”
Caregen plans to use this event as an opportunity to further strengthen its strategic relationship with its partners and to gradually implement various cooperation plans, including joint research and development, establishing localization strategies, and responding to overseas approvals.
- See more related articles
You must be logged in to post a comment.